Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
Age
18–74
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male and female subjects between 18 and 74 years of age, inclusive
Body weight \>/=45 kg and body mass index between 17 and 41 kg/m2, inclusive
Subjects with hepatic impairment must have a Child-Pugh score of 5 to 6 (mild), 7 to 9 (moderate), or 10 to 15 (severe) and have stable hepatic insufficiency within 1 month prior to Screening and a stable medication regimen for at least 1 month prior to Check-in
Agreement to use highly effective contraceptive methods as defined in the protocol
You may not be if
Significant illness, including infections, or hospitalization within the 2 weeks prior to dosing, except for subjects with hepatic impairment who due to their liver disease may be affected by significant medical problems which require frequent hospitalizations. Invasive systemic fungal infections need to be fully treated prior to study entry
Significant history or clinical manifestations of any cardiac event that would put the subject at risk in the opinion of the Investigator
Use of drugs of abuse within 1 month of Screening or during the entire study
Any acute or chronic condition that, in the opinion of the Investigator, would limit the subject's ability to complete and/or participate in this clinical study
